Advances in proteomic prostate cancer biomarker discovery
β Scribed by Young Ah Goo; David R. Goodlett
- Publisher
- Elsevier
- Year
- 2010
- Tongue
- English
- Weight
- 572 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1874-3919
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The advent of the prostateβspecific antigen (PSA) test has had a profound impact on the diagnosis and treatment of prostate carcinoma. However, the use of PSA levels alone for screening for prostate carcinoma was compromised by the variations in the amount of PSA produced
## Abstract Chromatography and electrophoresis have been used for the last halfβcentury to separate small and large molecules. Advances in MS instrumentation and techniques for sample introduction into the mass analyzer (i.e. matrixβassisted laser desorption/ionization and electrospray ionization),
"Secretome" is referred to as the rich, complex set of molecules secreted from living cells. In a less strict definition frequently followed in "secretome" studies, the term also includes molecules shed from the surface of living cells. Proteins of secretome (will be referred to as secreted) play a
## Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery A compelling need exists for the development of technologies that facilitate and accelerate the discovery of novel protein biomarkers with therapeutic and diagnostic potential. The inherent disadvant